T1	Participants 439 596	132 patients with hematological malignancy in complete remission without any main organ dysfunction who had been treated between April 1983 and December 1997
T2	Participants 614 714	incidence of ARDS due to pulmonary infection between those who received G-CSF and those who did not.
T3	Participants 336 424	G-CSF group which received chemotherapy with G-CSF and historical controls without G-CSF
